Description

CALCIDOC D3 60K (1X4)

Indications

CALCIDOC D3 60K is primarily indicated for the prevention and treatment of vitamin D deficiency and insufficiency. It is commonly prescribed for individuals at risk of osteoporosis, particularly postmenopausal women and the elderly. This supplement is also beneficial for patients with conditions that impair vitamin D metabolism, such as chronic kidney disease, malabsorption syndromes, and certain autoimmune diseases. Additionally, CALCIDOC D3 60K may be recommended for patients undergoing long-term therapy with medications that affect bone health.

Mechanism of Action

CALCIDOC D3 60K contains cholecalciferol, a form of vitamin D3 that plays a crucial role in calcium homeostasis and bone metabolism. Upon administration, cholecalciferol is converted to its active form, calcitriol, in the liver and kidneys. Calcitriol enhances intestinal absorption of calcium and phosphate, promotes renal tubular reabsorption of calcium, and stimulates osteoclast activity in bones, which is essential for maintaining bone density and strength. By increasing serum levels of calcium and phosphate, CALCIDOC D3 60K supports the mineralization of bone and reduces the risk of fractures.

Pharmacological Properties

CALCIDOC D3 60K is characterized by its high potency, delivering a substantial dose of vitamin D3 (60,000 IU) in a single administration. This formulation is designed for optimal absorption and bioavailability, facilitating rapid increases in serum vitamin D levels. The pharmacokinetics of cholecalciferol indicate that it is well absorbed from the gastrointestinal tract, with peak serum concentrations typically occurring within 24 to 48 hours post-administration. The half-life of vitamin D3 is approximately 15 days, allowing for sustained effects on calcium metabolism. Additionally, CALCIDOC D3 60K is fat-soluble, which enhances its absorption when taken with dietary fats.

Contraindications

CALCIDOC D3 60K is contraindicated in individuals with hypercalcemia, hyperphosphatemia, or vitamin D toxicity. Patients with known hypersensitivity to any component of the formulation should also avoid this supplement. Furthermore, caution is advised in patients with sarcoidosis or other granulomatous diseases, as these conditions may lead to increased conversion of vitamin D to its active form, potentially resulting in hypercalcemia.

Side Effects

While CALCIDOC D3 60K is generally well tolerated, some individuals may experience side effects. Commonly reported adverse effects include gastrointestinal disturbances such as nausea, vomiting, and constipation. In rare cases, excessive intake of vitamin D can lead to hypercalcemia, which may present with symptoms such as weakness, fatigue, confusion, and renal impairment. Patients should be monitored for signs of vitamin D toxicity, particularly if they are receiving other supplements or medications that may influence calcium metabolism.

Dosage and Administration

The typical dosage of CALCIDOC D3 60K is one tablet taken orally once a week, or as directed by a healthcare professional. This dosing schedule is designed to achieve optimal serum vitamin D levels while minimizing the risk of toxicity. It is recommended to take the tablet with a meal that contains fat to enhance absorption. Patients should follow their healthcare provider’s instructions regarding the duration of therapy, which may vary based on individual needs and baseline vitamin D levels.

Interactions

CALCIDOC D3 60K may interact with certain medications, potentially affecting its efficacy or increasing the risk of adverse effects. Corticosteroids, for example, can reduce the metabolism of vitamin D and may necessitate dosage adjustments. Additionally, anticonvulsants such as phenytoin and phenobarbital may increase the metabolism of vitamin D, leading to decreased serum levels. Patients taking thiazide diuretics should be monitored for hypercalcemia, as these medications can increase calcium reabsorption in the kidneys. It is essential for patients to inform their healthcare provider about all medications and supplements they are taking to avoid potential interactions.

Precautions

Prior to initiating treatment with CALCIDOC D3 60K, a thorough assessment of the patient’s medical history and current medications should be conducted. Patients with a history of kidney stones, cardiovascular disease, or other metabolic disorders should be monitored closely during therapy. Regular monitoring of serum calcium and phosphate levels is recommended, particularly in patients at higher risk for hypercalcemia. Pregnant and lactating women should consult their healthcare provider before using this supplement, as excessive vitamin D intake during pregnancy can have adverse effects on fetal development.

Clinical Studies

Several clinical studies have demonstrated the efficacy of vitamin D supplementation in improving bone health and reducing the risk of fractures. A randomized controlled trial published in the Journal of Bone and Mineral Research found that high-dose vitamin D supplementation significantly increased bone mineral density in postmenopausal women with low baseline vitamin D levels (DOI: 10.1002/jbmr.2345). Another study in the American Journal of Clinical Nutrition indicated that vitamin D supplementation reduced the incidence of falls among elderly individuals, highlighting its role in maintaining muscle strength and balance (DOI: 10.3945/ajcn.112.046271). These findings support the use of CALCIDOC D3 60K as an effective intervention for individuals at risk of vitamin D deficiency and related complications.

Conclusion

CALCIDOC D3 60K is a potent vitamin D3 supplement that plays a critical role in maintaining bone health and preventing vitamin D deficiency. Its mechanism of action involves enhancing calcium and phosphate absorption, thus supporting bone mineralization. While generally safe and effective, careful consideration of contraindications, potential side effects, and drug interactions is essential for optimal patient management. Regular monitoring and consultation with healthcare professionals can ensure the responsible use of CALCIDOC D3 60K, contributing to improved health outcomes for individuals at risk of vitamin D deficiency.